Difficulty: Medium
Average Score: 86%
Practice
Indicate the adrenomimetic, which cannot cross the blood-brain barrier:
Correct answer
D
Rationale
In the context of pharmacology, understanding the properties of adrenomimetics and their ability to cross the blood-brain barrier is crucial for safe and effective clinical practice. The correct answer, option D (All of the above), is the adrenomimetic that cannot cross the blood-brain barrier.
Epinephrine, norepinephrine, and phenylephrine are all adrenomimetics, but their structures and properties determine their ability to cross the blood-brain barrier. Epinephrine and norepinephrine are catecholamines, which have a hydroxyl group at the para position on the benzene ring. This hydroxyl group makes them polar molecules, limiting their ability to cross lipid-rich barriers like the blood-brain barrier.
On the other hand, phenylephrine lacks the hydroxyl group on the benzene ring, making it a non-catecholamine adrenomimetic. This structural difference allows phenylephrine to be more lipophilic and thus able to cross the blood-brain barrier to a certain extent.
Educationally, this question highlights the importance of understanding the pharmacokinetic properties of drugs in relation to their therapeutic effects. It emphasizes the need for healthcare professionals to be aware of which medications can cross certain physiological barriers, such as the blood-brain barrier, to predict their central nervous system effects. This knowledge is essential for making informed clinical decisions and ensuring patient safety.
Epinephrine, norepinephrine, and phenylephrine are all adrenomimetics, but their structures and properties determine their ability to cross the blood-brain barrier. Epinephrine and norepinephrine are catecholamines, which have a hydroxyl group at the para position on the benzene ring. This hydroxyl group makes them polar molecules, limiting their ability to cross lipid-rich barriers like the blood-brain barrier.
On the other hand, phenylephrine lacks the hydroxyl group on the benzene ring, making it a non-catecholamine adrenomimetic. This structural difference allows phenylephrine to be more lipophilic and thus able to cross the blood-brain barrier to a certain extent.
Educationally, this question highlights the importance of understanding the pharmacokinetic properties of drugs in relation to their therapeutic effects. It emphasizes the need for healthcare professionals to be aware of which medications can cross certain physiological barriers, such as the blood-brain barrier, to predict their central nervous system effects. This knowledge is essential for making informed clinical decisions and ensuring patient safety.